Methods:
We conducted a prospective age-matched study. Participants underwent comprehensive neurological and ophthalmological examinations. A high resolution spectral domain optical coherence tomography (HD-OCT) was used to determine peripapillary retinal nerve fiber layer (RNFL), macular thickness and volume.
Results:
Forty eight PD and 16 control eyes participated. Macular average thickness was significantly reduced in PD (275.4 ±17.4 vs. 286.9±10.3 μm, p=0.0026), as well as macular volume (9.93±0.82 vs. 10.34±0.36 mm3, p=0.007). Mean age was 62.3±8.0 vs. 58.1±9.3 years p=0.284). Inferior quadrant RNFL was thinner in PD 119.9±18.7 vs. controls 128.4±13.1 μm, p=0.049. The color vision was reduced in PD patients (4.61±1.22 vs. 5.13±0.34 p=0.009).Correlation analysis of OCT variables (RNFL, macular thickness and volume) and visual variables (color vision and contrast) revealed significant relation between macular volume and color vision (r=0.549, p= 0.00023) in PD patients. Mean RNFL and macular thickness did not significantly correlat with motor Unified Parkinson's disease rating scale.
Conclusion:
The results show that macular thickness is reduced in PD patients. This finding is more prominent than the RNFL thinning. OCT parameters correlated with significant reduction in color vision observed in our PD patients. This correlation had not been described before. Macular thickness and RNFL reduction have been reported in smaller groups of PD patients using earlier time-domain OCT. Our results, using spectral domain HD-OCT with superior resolution and stability, confirm these findings in a larger age-matched group and also establish the correlation with decreased color vision. 3 In addition to early-onset severe peripheral neuropathy, affected individuals also develop progressive optic nerve dysfunction in later childhood. MFN2 is a critical mitochondrial outer membrane protein and it shares a remarkable degree of structural and functional complementarity with OPA1, a mitochondrial inner membrane protein implicated in the majority of cases of autosomal-dominant optic atrophy (ADOA, OMIM 165500). 4, 5 The aim of this study was to provide new mechanistic insights by investigating the deleterious influence of MFN2 mutations on mitochondrial biogenesis.
Methods:
Tissue samples were available from 48 patients with confirmed MFN2 mutations. Using well-established molecular protocols, various markers of mitochondrial dysfunction were assayed including: (i) mitochondrial DNA (mtDNA) proliferation in blood leukocytes, (ii) the presence of biochemically-defective cytochrome c oxidase (COX) fibres in skeletal muscle biopsies, and (iii) the kinetics of mtDNA repopulation in fibroblast cultures after ethidium bromide-induced depletion.
Results:
Blood leukocytes from MFN2-positive patients had significantly increased mtDNA copy numbers (Mean = 205.9, n = 48) compared with age-matched controls (Mean = 60.9, n = 131; p < 0.0001). Significant mtDNA proliferation was also evident in skeletal muscle fibres from MFN2-positive patients. COX-negative skeletal muscle fibres were present and these harboured high levels of somatic mtDNA deletions, accounting for the observed respiratory chain defect. MFN2-positive fibroblasts had significantly impaired rates of mtDNA repopulation following a period of increased cellular stress.
Conclusion:
The MFN2 protein is intricately involved in mtDNA maintenance and the faithful replication of the mitochondrial genome. Pathogenic MFN2 mutations ultimately lead to neuronal cell loss by triggering a mitochondrial biochemical defect.
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Introduction:
Magnetic resonance imaging (MRI) is widely used as a surrogate marker in the assessment of patients with multiple sclerosis (MS). An alternative to MRI which was equally informative but cheaper, more patient-friendly, and more easily accessible would be highly desirable. Multifocal objective pupil perimetry (mfPOP) may be suitable.
Methods:
85 subjects with MS (49.8 ± 11.3 yr, 62 women) and 35 normal controls (47.9 ± 16.8 yr, 22 women) were enrolled. 72 patients had relapsing remitting MS (RR), 13 had progressive MS (PS). The mean (± SD) EDSS score was 3.5 ± 1.0 (RR) and 5.9 ± 1.4 (PS). All subjects underwent MRI and mfPOP. MRI measures included T1 and T2 lesion volumes (LVs), brain parenchymal fractions (BPFs), and regional brain volumes (BVs). mfPOP responses were obtained from 44 regions per visual field. Each region was analysed according to response time-to-peak and standardized amplitude (AmpStd). The accuracy of predicting MS disease status was determined from the percentage area under the receiver operator curve (%AUC).
Results:
mfPOP responses showed a significant reduction of 0.69 ± 0.04 dB in AmpStd and a delay in time-to-peak of 25.95 ± 0.89 ms in MS patients; the delay had a trend towards linearity with the EDSS score. There was no significant difference in BPF between MS subjects and controls and, of the BVs, only the basal-ganglia-plus-thalamic volumes in the PS group showed a significant decrease (-1.07 ± 0.4 dB, P = 0.01). mfPOP %AUCs for RR and PS groups were 75.0 ± 3.3 and 94.8 ± 3.6, respectively. For BPF, %AUCs were 61.6 ± 4.9 (RR) and 72.2 ± 6.3 (PS). For BVs they were 63.0 ± 4.4 (RR) and 75.4 ± 7.4 (PS).
Conclusion:
mfPOP is inexpensive and well-tolerated. It has the potential to complement MRI as a surrogate marker for MS disease activity. 
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Methods:
We studied fMRI activation patterns during comprehension of spoken language in a population of 10 early-blind participants and 10 sighted controls. We systematically varied the semantic content of the stimuli to represent either visual, tactile, or auditory information (with white noise and reverse language control conditions).
Results:
Bulk activity within striate cortex during language processing was greater for blind than sighted subjects. However, across conditions of varied semantic content in the blind, bulk striate cortex activity was equivalent. On the other hand, multivoxel pattern analysis (Kriegeskorte 2006) demonstrated that striate cortex in the blind (but not the sighted) exhibits above-chance classification accuracy for pair-wise comparisons between semantic categories. Furthermore, whole-brain analysis of classification accuracy (for blind and sighted groups, collapsing across all pair-wise comparisons of semantic categories) revealed that blind subjects possess extensive occipital areas (with left hemispheric predominance) capable of semantic category discrimination.
Conclusion:
While it is well established that occipital areas demonstrate cross-modal plasticity in the setting of early visual loss, these data specify a role of category discrimination within larger sematic processing networks. 
Introduction:
Optic neuropathies are the leading cause of irreversible blindness worldwide and lack adequate treatment options. In order to investigate a novel approach to treatment, we tested the capacity of neuroprotective drugs to cross the optic nerve sheath in vitro.
Methods:
Optic nerves from two pigs at time of death and optic nerves from two humans at time of globe enucleation were harvested. A diffusion cell was designed with optic nerve sheath as membrane to test meningeal penetration by both brimonidine alone and brimonidine encapsulated in nanoparticle (NP-brimonidine). A UV-VIS spectrophotometer was used to measure concentration in the donor and receptor chambers over time.
Results:
Increasing concentration in the receiver chamber was measured in the brimonidine alone and the NPbrimonidine experiments when tested with either pig or human meninges. The human data was fitted with a two parameter exponential regression analysis (brimonidine alone donor r 2 = 0.87, receiver r 2 = 0.795; NP-brimonidine donor r 2 = 0.79, receiver r 2 = 0.986). The time constant (τ,) was 10.2 hours (donor) and 13.09 hours (receiver) in the brimonidine study, and 24 hours (donor) and 15.84 hours (receiver) in the NP-brimonidine study. The encapsulated brimonidine had a longer time to reach equilibrium ( Figure 1) . Figure 1 . Diffusion of brimonidine through human meninges: brimonidine alone (left), NP-brimonidine (right).
Conclusion:
Passage of brimonidine through the optic nerve sheath was demonstrated. The increase in time constants when comparing the NP-brimonidine to the brimonidine curves in the human studies supports that diffusion is delayed by drug being loaded in NP. We envision employing the transmeningeal route using the imageguided orbital endoscope and the novel polyester nanoparticle (NP) drug delivery system created by members of our team for the ultimate goal of sustained-released neuroprotective agents directly delivered to the ganglion cell axons of the optic nerve. 
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Introduction:
To evaluate the ability of Fourier-domain optical coherence tomography (FD-OCT) macular thickness parameters to differentiate between eyes with chronic papilledema and healthy eyes and to investigate the relationship of such parameters with visual field (VF) loss assessed on standard automated perimetry (SAP).
Methods:
Fifty-eight eyes from 31 patients with chronic papilledema from pseudotumor cerebri syndrome and 78 eyes from 39 normals underwent FD-OCT (3D OCT-1000 ® , Topcon) examinations and ophthalmic evaluation including SAP. All patients had been submitted to previous treatment of the condition and had resolved papilledema. Macular thickness measurements were determined in both groups. Comparisons were made using Generalized Estimated Equations. Correlations between OCT and VF measurements were also verified.
Results:
In eyes with papilledema macular thickness parameters (mean ± SD) corresponding to the superior, temporal, inferior and nasal, inner and outer segments in papilledema eyes were: 283.5 ± 24.2; 271.1 ± 19.4; 282.0 ± 23.0; 284.6 ± 26.2; 245.2 ± 16.9; 231.4 ± 13.1; 238.2 ± 18.6 and 257.2 ± 24.5, respectively. Average macular thickness was 258.7 ± 18.3. Corresponding values from normal eyes were: 295.1 ± 18.8; 281.5 ± 15.5; 289.9 ± 17.0; 298.2 ± 16.3; 256.2 ± 15.2; 240.8 ± 13.3; 250.8 ± 16.2 and 275.9 ± 15.5. Average macular thickness measurement was 270.8 ± 12.9. Macular and RNFL thickness parameters were significantly reduced in papilledema eyes compared to normals. Macular thickness measurements were strongly correlated with VF sensitivity loss assessed with SAP.
Conclusion:
Eyes with chronic papilledema show significant thinning of the retinal thickness on the macular area, which is associated with the severity of visual field damage in these eyes. Macular thickness measurements could potentially be used to evaluate the amount of ganglion cell loss in patients with papilledema from pseudotumor cerebri syndrome.
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Introduction:
To determine the effect of deficient contrast sensitivity visual acuity on gait performance since injurious falls in Parkinson Disease are a major healthcare concern and cost.
Methods:
Fifty one Parkinson's subjects (Stage I-III H and Y) versus thirty controls. Tests included UPDRS scores, directive & contrast sensitivity binocular visual acuities using SLOAN wall charts tested at 100%, 2.5%, and 1.25%, as well as gait analysis (GaitRite) under conditions of high and low illumination (>80 & <4 candela). Gait measurements included: functional ambulation profile (FAP), step number, velocity, normalized velocity, step length, step length differential, stride length, & cadence. Exclusion criteria: VA <20/50, known night blindness, heart disease, known co-morbid neurologic or vestibular dysfunction.
Results:
Compared with controls, there was significantly poorer contrast visual acuity in the Parkinson's group at 2.5% and 1.25% visual efficiency, an observation we have previously reported 1 . Further, such visual deficiency significantly degraded motor performance when compared to controls. In high illumination, PD subjects had a statistically significant difference in step cadence only. In dim illumination, PD subjects displayed poorer performances in FAP, velocity, normalized velocity, cadence, step length, and stride length.
Conclusion:
This study confirms the presence of contrast sensitivity deficits that significantly degrade motor performance in Parkinsonism under conditions of low illumination, presumably the result of retinal dopamine deficiency 2 , associated with inner retinal layer thinning 3 . Substandard FAP scores are particularly meaningful as there is high correlation between low FAP scoring and increased fall risk 4 . It appears that balance maintenance is affected even in early stages of Parkinsonism. It seems plausible that detection of defects in low contrast visual settings may aid in reduction of falls risk. Further study is required to determine if identification of low contrast sensitivity defects may serve as a premotoric marker for Parkinsonism. 
Introduction:
The ocular vestibular evoked myogenic potential (oVEMP) is a vestibular-dependent reflex and clinical test of otolith function measured from the extraocular muscles with surface electrodes. Since it is not known exactly which muscles contribute to the reflex, we wished to determine the muscle of origin of the oVEMP and investigate the neural pathway of the vestibulo-ocular reflex (VOR) to individual eye muscles.
Methods:
Three healthy subjects were stimulated with 500Hz, 4ms bursts of vibration and sound. Motor units from the inferior oblique (IO) and inferior rectus (IR) eye muscles were recorded with concentric needle electrodes. Standard oVEMPs were recorded simultaneously with surface electrodes placed below the eyes. Single motor units were extracted from multi-unit recordings and quantified in peri-stimulus histograms.
Results:
Following vibration, an initial increase in IO single motor unit discharge was measured at a mean peak latency of 11.0ms (range 10-13ms, n=6 units). Discharge was up to 10 times baseline level during the pre-stimulus period. The initial peak was followed by subsequent troughs and peaks at intervals of ~5ms. In the IR muscle, a similar pattern of alternating excitation and inhibition was seen, but was delayed by ~5ms compared to the IO muscle. Following sound stimulation, an increase in IO activity was seen in the muscle contralateral to the stimulus at a mean latency of 13.8ms. The latency and polarity of the simultaneous surface oVEMP were similar to the IO needle recordings.
Conclusion:
The study identifies excitation of the IO as the source of the initial oVEMP signal in response to vibration and sound. Its vertical antagonist, the IR, shows delayed excitation by ~5ms but does not contribute to the initial response. These muscles show reciprocal activation, consistent with their role as vertical antagonists. Single motor unit recordings in human extraocular muscles demonstrate the contribution of individual muscles to the VOR.
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Introduction:
At NANOS 2011, we presented data demonstrating a strong association between a strain of Burkholderia similar to B. pseudomallei and giant cell artieritis (GCA). Since then, we have isolated, cultured and characterized this strain. We found this strain to be sensitive to minocycline in vitro. To better understand the pathogenesis of human infection, we infected mice with this Burkholderia pseudomallei-like strain.
Methods:
24 mice received intraperitoneal injection of these bacteria. 6 mice received steroids+minocycline, 6 mice received steroids alone, 6 mice received minocycline alone, and 6 mice received no therapy. Kaplan-Meier curves of survival were plotted over 30 hours.
Results:
The mice receiving no therapy quickly became sick and half were dead 30 hours after injection with the bacteria. Four of the mice that received minocycline alone were still alive at 30 hours. Five of the mice that received steroids alone were still alive at 30 hours. All 6 mice that received steroids+minocycline were still alive at 30 hours. Histologic sections taken from mice that did not receive treatment showed widespread infection, including liver, lung and spleen. Bacterial burden was significantly reduced in the tissues of animals that had received minocycline alone. Bacterial burden was not significantly reduced in the tissues of animals that had received steroids alone. Sections taken from lung showed lymphocytic infiltration of blood vessels (vasculitis) and bronchioles (bronchiolitis).
Conclusion:
If this B pseudomallei-like strain is indeed the cause of GCA, this model may explain why steroids are an effective treatment in humans. These results indicate that the immune response to infection with this strain may be more damaging to the host than the bacterial infection itself. These results indicate that it may be unwise to attempt a clinical trial of antibiotics alone to treat GCA. Instead, a trial comparing steroids+antibiotics should be compared to steroids+placebo.
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